rs193302913
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000202.8(IDS):c.908_909del(p.Ser303CysfsTer38) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 22)
Consequence
IDS
NM_000202.8 frameshift
NM_000202.8 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.39
Genes affected
IDS (HGNC:5389): (iduronate 2-sulfatase) This gene encodes a member of the sulfatase family of proteins. The encoded preproprotein is proteolytically processed to generate two polypeptide chains. This enzyme is involved in the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this gene are associated with the X-linked lysosomal storage disease mucopolysaccharidosis type II, also known as Hunter syndrome. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-149490410-CAG-C is Pathogenic according to our data. Variant chrX-149490410-CAG-C is described in ClinVar as [Pathogenic]. Clinvar id is 221217.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-149490410-CAG-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDS | NM_000202.8 | c.908_909del | p.Ser303CysfsTer38 | frameshift_variant | 7/9 | ENST00000340855.11 | NP_000193.1 | |
IDS | NM_001166550.4 | c.638_639del | p.Ser213CysfsTer38 | frameshift_variant | 7/9 | NP_001160022.1 | ||
IDS | NM_006123.5 | c.908_909del | p.Ser303CysfsTer50 | frameshift_variant | 7/8 | NP_006114.1 | ||
IDS | NR_104128.2 | n.1207_1208del | non_coding_transcript_exon_variant | 8/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDS | ENST00000340855.11 | c.908_909del | p.Ser303CysfsTer38 | frameshift_variant | 7/9 | 1 | NM_000202.8 | ENSP00000339801 | P1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Mucopolysaccharidosis, MPS-II Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Feb 17, 2022 | - - |
Pathogenic, criteria provided, single submitter | research | IIFP, CONICET-UNLP | Apr 01, 2011 | - - |
Pathogenic, criteria provided, single submitter | literature only | Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova | Jun 07, 2024 | Null variant (PVS1_VeryStrong), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at